The major histocompatibility complex (MHC) class I gene HLA-B27 has a striking association with a group of inflammatory human disorders that affect the bowel, the joints and the axial skeleton.
is a result of high levels of HLA-B27 expression, which rises in aging and is not merely a consequence of an ongoing inflammatory state [2] . The [2] . In these rats, diarrhoea is the earliest clinical manifestation [1] , appearing after 10 weeks of age. Within several weeks of the onset of intestinal inflammation, most affected rats develop peripheral arthritis [1] [2] [3] [4] [5] . In 21-4H, arthritis follows closely the onset of diarrhoea, whereas in 33-3 male B27TR diarrhoea appears earlier than in 21-4H and other manifestations appear later. In most cases, arthritis is characterized by swelling, erythema and tenderness of the tarsal joints of one or both hind limbs [1] . Arthritis persists from few days to several weeks, and in some cases shows a cyclical pattern of remission and exacerbation [1] . Involved joints show pathological modifications commonly seen in experimental arthritis in rats and peripheral arthritis in human beings. These modifications are characterized by synovial hyperplasia, pannus formation, inflammatory cell infiltrate and destruction of articular cartilage and bone [1] . [1] .
Fibrotic ankylosis occurs where the articular cartilage on adjacent joint surface is completely replaced by pannus. Usually, chronic inflammation involves the joint capsule and the adjacent ligaments and tendons [1]. The vertebral lesion observed in the tail of the 21-4H rats closely resembles the enthesitis, inflammation at ligamentous attachments to bone
Several mediators of inflammation were detected in B27TR colonic mucosa and these rats have been used for several years to evaluate the activity and mechanisms of action of anti-inflammatory molecules [6] [7] [8] [9] . [10] [11] [12] . Furthermore, dense cellular infiltrate of T cells and macrophages with enhanced expression of TNF-␣ has been found in the joints of patients with ankylosing spondylitis [13] . Anti-TNF-␣ agents are now used in the treatment of ankylosing spondylitis and inflammatory bowel disease (IBD), although not all are equally effective [14] . Besides joint inflammation, increasing evidence suggests that, in animal models of SpA as well as in patients, new cartilage and bone formation is a major player in the pathological manifestations leading to ankylosis [15] 
In the mucosa of B27TR with advanced gut disease, tumour necrosis factor ␣ (TNF-␣) is increased and, for this reason, its role in sustaining chronic mucosal inflammation has been suggested

Sample collection and histological evaluation
The dissected colon was prepared for routine histology and paraffin sections (5 m thick) were cut across the longitudinal axis, and stained with haematoxylin and eosin. The sections were scored blindly by two investigators for histological evidence of inflammation and structural damage, as previously described [16] . [16] .
In each animal, pathological parameters in peripheral joints were blindly evaluated and scored by two investigators, as above described, and the results are reported in Fig. 3 . In IgG2a,k-treated rats, peripheral joints showed diffuse subcutaneous oedema and inflammatory infiltrate in the plantar fascia, whereas the overlying skin appeared normal, without signs of hyperkeratosis or dermal hyperplasia. Around tendons a diffuse inflammatory infiltrate was evident, and cell infiltration extended into the entheseal region (Fig. 1B-E (Fig. 1E, F) . (Fig. 5A, B) . Moreover, proliferating and prehypertrophic chondrocyte-like cells showed strong p-Smad1/ 5/8-immunopositivity in the fibrocartilage at the point of entheseal attachment (Fig. 5C, D) . Instead, hypertrophic chondrocytes were negative (Fig. 5D) . Chondrocytes in the articular cartilage were also found positive for p-Smad1/5/8 (Fig. 5E, F Fig. 3A . (Fig. 5G, H) .
Immunohistochemistry was performed to identify cells expressing TNF-␣ in the affected joints of IgG2a,k-treated B27TR. In both 18-and 27-week-old rats, chondrocyte-like cells showed
Fig. 1 Macroscopic and microscopic features of joint disease in IgG2a,k-treated HLA-B27 transgenic rats (B27TR). (A) Oedema and erythema in the hind paw. (B)-(K) Representative histological sections of peripheral joints (B, E: haematoxylin and eosin staining, F: Goldner's Masson trichrome staining, (G)-(K) toluidine blue staining). (B) Subcutaneous inflammatory infiltrate (asterisk) and oedema close to the enthesis and tendons in a 18-weekold rat. (C), (D) Representative microphotographs of immunostaining for CD3 and CD68 in the same rat showed in (B). (C) Immunohistochemistry
Early anti-TNF-␣ treatment
The early TNF-␣ blockade, started at the age of 9 weeks before the onset of any symptoms, prevented the appearance of diarrhoea and the stool score remained normal. During the treatment no clinical signs of oedema and erythema were observed in the peripheral joints. In these rats there was no evidence of inflammatory infiltrate within the colonic mucosa and submucosa, and we did not observe the architectural damage seen in the IgG2a,ktreated rats (Fig. 2A). No inflammatory infiltrate was detected into the joints and periarticular tissue, and the organization of the articular cartilage and entheses, with regular tidemarks and aligned chondrocyte rows towards the ligament, was maintained (Fig. 2B-D). In these rats, bone erosion was never detected. Results of the histological joint score are reported in
TNF-␣ was not detected in the peripheral joints of early treated rats, neither at the cartilage nor at the enthesis (Fig. 4D). Activation of Smad1/5/8 signalling was not found in these rats
Late anti-TNF-␣ treatment
In rats treated late with the anti-TNF-␣ mAb, clinical signs of gut inflammation and stool score decreased after the first week of treatment, and then normalized. Three out of six animals showed only episodes of transient erythema and oedema in the hind paws, with a mean joint score of 6.0 Ϯ 1. Two out of six rats had a complete remission, while one animal manifested no signs of arthritis during the experiments. In the colon, the late anti-TNF-␣ treatment did not significantly reduce the inflammatory features and did not lead to the repair of the architectural damages (Fig. 2E). Instead, the treatment effectively reduced joint inflammatory infiltrate in the subcutaneous tissue. The three B27TR with clinical episodes of erythema and oedema during treatment developed areas of superficial matrix pallor due to degeneration/necrosis of chondrocytes in the articular cartilage (Fig. 2F). In these rats, bone erosion was seldom detected. In the entheses, irregular tidemark between fibrocartilage and bone, chondrocytes not aligned in rows, areas of chondrocyte proliferation and endochondral bone ossification
were found (Fig. 2G, H) 
Discussion
Our data confirm that in B27TR gastrointestinal involvement always precedes joint involvement [1-5, 11, 12] [17, 18] , in the affected entheseal region and in the articular cartilage of IgG2a,k-treated rats support this hypothesis. [19, 20] , although the functional relationship between the enthesis and the adjacent synovium is not yet fully understood [19] . Previous studies on 33-3 lines on Fisher 344 background rats showed a synovial involvement 
It is known that entheseal involvement is a pivotal event in the development of SpA in human beings
B27TR). (A)-(D) Early anti-TNF-␣ treatment. (A) Histological section of colon in early-treated B27TR (haematoxylin and eosin staining). (B), (C) Representative histological sections of peripheral joint, with well preserved articular components. (D) Normal organization of the enthesis, with regular tidemarks and aligned chondrocyte rows towards the ligament. (B-D: toluidine blue staining). Original magnification: (A, C) ϫ10; (B) ϫ4; (D) ϫ40. (E)-(H) Late anti-TNF-␣ treatment. (E) Histological section of colon in late-treated B27TR (haematoxylin and eosin staining). (F)-(H) The histopathological joint features of three out of six late anti-TNF-␣ treated B27TR are shown. The other three late treated-B27TR showed no significant joint alterations as in the early treated group (B-D). (F) Areas of superficial matrix pallor, with hypertrophic chondrocytes and undulating articular surface. (G) Irregular tidemark between fibrocartilage and bone and endochondral bone ossification (arrow). (H) Bone erosion at the enthesis (arrow). [(F-H) toluidine blue staining]. Original magnification: (E-G)
with an arthritis pattern, but not entheseal involvement [4, 6] . In 33-3 line on LEW background rats, Tran et al. found that the additional h␤2m promotes arthritis and spondylitis, in the absence of gut inflammation [21] . Clinical features of arthritis were found in the hind paws, while enthesitis was observed in the tail vertebral joints from 31-week-old rats. Thus, the authors suggested that the genetic background may have a strong influence on the incidence, pattern and severity of the disease [21] [22, 23] . The role of TNF-␣ and anti-TNF-␣ strategies on disease evolution in enthesitis-related disorders is an important and debated topic. In human SpA, TNF-␣ blockers effectively inhibit inflammation, as shown by signs and symptoms, and will probably prevent erosive structural damage [23] . However, the ossification of already-damaged bone cannot be influenced by TNF-␣ blockers, because these drugs do not inhibit chondrogenesis [23] . It has also been suggested that inflammation and ankylosis may be linked in some manner, but both are largely independent processes and are probably controlled by different genetic susceptibility factors [22, 23] . The present study cannot solve this important debate, which seems in part related to the specific animal models used in different studies [22] already suggested in the case of human beings [20] . This may suggest that anti-TNF-␣ treatment should be started as early as possible to prevent the disease evolution and the development of enthesitis and later synovitis.
